公司概覽
業務類別 Diagnostics & Research
業務概覽 Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ inthe office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
公司地址 One IDEXX Drive, Westbrook, ME, USA, 04092
電話號碼 +1 207 556-0300
傳真號碼 +1 207 556-4346
公司網頁 https://www.idexx.com
員工數量 11000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Michael G. Erickson, PhD Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine -- 13/01/2026
Mr. Andrew J. Emerson Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer -- 20/02/2026
Mr. George J. Fennell Executive Vice President, Global CAG Commercial -- 28/03/2025
Mr. Jonathan J. Mazelsky Director, President and Chief Executive Officer 美元 1.12M 13/01/2026
Dr. Martin Alexander Smith, PhD Executive Vice President, Global Operations and Research and Development 美元 576.64K 28/03/2025
Ms. Sharon E. Underberg Executive Vice President, General Counsel and Corporate Secretary -- 28/03/2025
Mr. Michael J. Lane Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology 美元 576.64K 28/03/2025
Dr. Nimrata Khatra Hunt, PhD Executive Vice President, Global Strategy and Commercial 美元 576.64K 28/03/2025
Mr. Michael Schreck Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience -- 28/03/2025
Mr. Michael P. Johnson Senior Vice President and Chief Human Resources Officer -- 28/03/2025
 
董事會成員
董事會 職務 更新日期
Mr. Bruce L. Claflin Independent Director 20/02/2026
Mr. Daniel M. Junius Independent Director 20/02/2026
Ms. M. Anne Szostak Independent Director 13/02/2026
Mr. Lawrence D. Kingsley Non-Executive Chairman of the Board 20/02/2026
Dr. Sophie V. Vandebroek, PhD Independent Director 20/02/2026
Mr. Stuart M. Essig, PhD Independent Director 20/02/2026
Mr. Jonathan J. Mazelsky Director, President and Chief Executive Officer 13/01/2026
Mr. Sam A. Samad Independent Director 20/02/2026
Mr. Joseph L. Hooley Independent Director 20/02/2026
Ms. Karen A. Peacock Independent Director 20/02/2026
Ms. Irene Chang Britt Independent Director 20/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:18)
代號 名稱 佔比% 持有日期
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
SSOProShares Ultra S&P5000.01%27/02/2026
RONBBaron First Principles ETF0.01%28/02/2026
SCHKSchwab 1000 ETF0.01%28/02/2026
BXMXNuveen S&P 500 Buy-Write Income0.01%31/12/2025
USCAXtrackers MSCI USA Clmt Actn Eq ETF0.01%26/02/2026
SPXLDirexion Daily S&P500® Bull 3X ETF0.01%26/02/2026
PTNQPacer Trendpilot™ 100 ETF0.01%27/02/2026
MSLCMorgan Stanley Pathway Large Cap Eq ETF0.01%28/02/2026
AVLVAvantis US Large Cap Value ETF0.01%28/02/2026
SPUSSP Funds S&P 500 Sharia Industry Ex ETF0.01%27/02/2026
QQXTFirst Trust NASDAQ-100 ex-Tech Sect ETF0.01%26/02/2026
GSEWGoldman Sachs Equal Wght US Lg Cp Eq ETF0.01%27/02/2026
PCLGPolen Focus Growth ETF0.01%31/12/2025
OMFLInvesco Russell 1000® Dynamic Mltfct ETF0.01%27/02/2026
EUSAiShares MSCI USA Equal Weighted ETF0.01%28/02/2026
USCLiShares Climate Conscious &TrnMSCIUSAETF0.01%28/02/2026
GQINatixis Gateway Quality Income ETF0.01%28/02/2026
AVMVAvantis U.S. Mid Cap Value ETF0.01%28/02/2026
XYLDGlobal X S&P 500® Covered Call ETF0.01%27/02/2026
  1    2    3    4   5    6    7    8    9    10    11    12    13    14    15    16  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.